[{"address1": "3020 Carrington Mill Blvd.", "address2": "Suite 475", "city": "Morrisville", "state": "NC", "zip": "27560", "country": "United States", "phone": "212 554 4484", "fax": "212 554 4531", "website": "https://www.tgtherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. The company was incorporated in 1993 and is based in Morrisville, North Carolina.", "fullTimeEmployees": 374, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Weiss Esq., J.D.", "age": 59, "title": "Chairman, CEO & President", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1970938, "exercisedValue": 0, "unexercisedValue": 26229992}, {"maxAge": 1, "name": "Mr. Sean A. Power CPA", "age": 43, "title": "CFO, Corporate Secretary & Treasurer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 780600, "exercisedValue": 0, "unexercisedValue": 8840500}, {"maxAge": 1, "name": "Ms. Jenna  Bosco", "title": "Senior Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Waldman", "title": "Chief Commercialization Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 10, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.5, "open": 30.69, "dayLow": 28.21, "dayHigh": 30.9, "regularMarketPreviousClose": 30.5, "regularMarketOpen": 30.69, "regularMarketDayLow": 28.21, "regularMarketDayHigh": 30.9, "payoutRatio": 0.0, "beta": 1.864, "trailingPE": 10.277978, "forwardPE": 15.134439, "volume": 3210049, "regularMarketVolume": 3210049, "averageVolume": 1798537, "averageVolume10days": 1934100, "averageDailyVolume10Day": 1934100, "bid": 26.8, "ask": 35.4, "bidSize": 1, "askSize": 1, "marketCap": 4519881728, "fiftyTwoWeekLow": 25.28, "fiftyTwoWeekHigh": 46.48, "allTimeHigh": 233.4375, "allTimeLow": 0.95625, "priceToSalesTrailing12Months": 8.497648, "fiftyDayAverage": 31.3498, "twoHundredDayAverage": 34.22345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4285210624, "profitMargins": 0.84128, "floatShares": 140386483, "sharesOutstanding": 158759451, "sharesShort": 25111351, "sharesShortPriorMonth": 25224861, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1582, "heldPercentInsiders": 0.06784, "heldPercentInstitutions": 0.65147, "shortRatio": 15.25, "shortPercentOfFloat": 0.2068, "impliedSharesOutstanding": 158759451, "bookValue": 4.256, "priceToBook": 6.6893797, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 99.746, "netIncomeToCommon": 447472992, "trailingEps": 2.77, "forwardEps": 1.88114, "lastSplitFactor": "100:5625", "lastSplitDate": 1335744000, "enterpriseToRevenue": 8.056, "enterpriseToEbitda": 41.674, "52WeekChange": 0.028912187, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 28.47, "targetHighPrice": 60.0, "targetLowPrice": 15.0, "targetMeanPrice": 44.57143, "targetMedianPrice": 49.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 131582000, "totalCashPerShare": 0.9, "ebitda": 102826000, "totalDebt": 254540000, "quickRatio": 2.532, "currentRatio": 3.825, "totalRevenue": 531897984, "debtToEquity": 41.919, "revenuePerShare": 3.643, "returnOnAssets": 0.07975, "returnOnEquity": 1.11956, "grossProfits": 453927008, "freeCashflow": -94664496, "operatingCashflow": -70073000, "earningsGrowth": 120.5, "revenueGrowth": 0.928, "grossMargins": 0.85341, "ebitdaMargins": 0.19332, "operatingMargins": 0.18159, "financialCurrency": "USD", "symbol": "TGTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 28.5, "postMarketChange": 0.030000687, "regularMarketChange": -2.03, "regularMarketDayRange": "28.21 - 30.9", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1798537, "fiftyTwoWeekLowChange": 3.1899986, "fiftyTwoWeekLowChangePercent": 0.12618665, "fiftyTwoWeekRange": "25.28 - 46.48", "fiftyTwoWeekHighChange": -18.01, "fiftyTwoWeekHighChangePercent": -0.3874785, "fiftyTwoWeekChangePercent": 2.8912187, "corporateActions": [], "postMarketTime": 1768006789, "regularMarketTime": 1767992401, "exchange": "NCM", "messageBoardId": "finmb_143627354", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.65574, "regularMarketPrice": 28.47, "marketState": "CLOSED", "shortName": "TG Therapeutics, Inc.", "longName": "TG Therapeutics, Inc.", "earningsTimestamp": 1762176600, "earningsTimestampStart": 1762176600, "earningsTimestampEnd": 1762176600, "earningsCallTimestampStart": 1762176600, "earningsCallTimestampEnd": 1762176600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.77, "epsForward": 1.88114, "epsCurrentYear": 2.95171, "priceEpsCurrentYear": 9.645256, "fiftyDayAverageChange": -2.8798008, "fiftyDayAverageChangePercent": -0.09186026, "twoHundredDayAverageChange": -5.7534504, "twoHundredDayAverageChangePercent": -0.16811427, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1272893400000, "postMarketChangePercent": 0.10537649, "displayName": "TG Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]